Human leukocyte antigen-DQB1 and -DRB1 associations in patients with idiopathic sudden sensorineural hearing loss from a defined population of Northwest Spain

References

• Koc A, Sanisoglu O. Sudden sensorineural hearing loss: literature survey on recent studies. J Otolaryngol 2003; 32: 308–13
   PubMedGoogle Scholar
• Shikowitz MJ. Sudden sensorineural hearing loss. Med Clin North Am 1991; 75: 1239–50
   PubMed Web of Science ®Google Scholar
• Mattox DE, Lyles CA. Idiopathic sudden sensorineural hearing loss. Am J Otol 1989; 10: 242–7
   PubMedGoogle Scholar
• Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double blind clinical study. Arch Otolaryngol 1980; 106: 772–6
   PubMed Web of Science ®Google Scholar
• Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205–13
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 2002; 31: 355–60
   PubMed Web of Science ®Google Scholar
• Yeo SW, Chang KH, Suh BD, Kim TG, Han H. Distribution of HLA-A, -B and -DRB1 alleles in patients with sudden sensorineural hearing loss. Acta Otolaryngol 2000; 120: 710–5
   PubMed Web of Science ®Google Scholar
• Yeo SW, Park SN, Park YS, Suh BD, Han H, Choi HB, et al. Different distribution of HLA class II alleles according to response to corticosteroid therapy in sudden sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2001; 127: 945–9
   PubMedGoogle Scholar
• Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitis in adults in northwestern Spain, 1988–1997. Clinical and epidemiologic aspects. Medicine (Baltimore) 1999; 78: 292–308
   PubMed Web of Science ®Google Scholar
• Amor-Dorado JC, Llorca J, Garcia-Porrua C, Costa C, Perez-Fernandez N, Gonzalez-Gay MA. Audiovestibular manifestations in giant cell arteritis: a prospective study. Medicine (Baltimore) 2003; 82: 13–26
   PubMed Web of Science ®Google Scholar
• Monsell EM, Balkany TA, Gates GA, Goldenberg RA, Meyerhoff WA, House JW. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995; 113: 181–5
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Hajeer AH, Garcia-Porrua C, Dababneh A, Thomson W, Ollier WE, et al. Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset. J Rheumatol 2002; 29: 271–5
   PubMed Web of Science ®Google Scholar
• Bernstein JM, Shanahan TC, Schaffer FM. Further observations on the role of the MHC genes and certain hearing disorders. Acta Otolaryngol (Stockh) 1996; 116: 666–71
   PubMed Web of Science ®Google Scholar
• Cao MY, Thonnard J, Deggouj N, Gersdorff M, Phillippe M, Osselaer JC, et al. HLA class II-associated genetic susceptibility in idiopathic progressive sensorineural hearing loss. Ann Otol Rhinol Laryngol 1996; 105: 628–33
   PubMed Web of Science ®Google Scholar
• Hajeer AH, Dababneh A, Makki RF, Thomson W, Poulton K, Gonzalea-Gay MA, et al. Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients. Tissue Antigens 2000; 55: 319–25
   PubMed Web of Science ®Google Scholar
• Roep BO, Schipper R, Verduyn W, Bruining GJ, Schreuder GM, de Vries RR. HLA-DRB1*0403 is associated with dominant protection against IDDM in the general Dutch population and subjects with high-risk DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype. Tissue Antigens 1999; 54: 88–90
   PubMedGoogle Scholar
• Donner H, Seidl C, Van der Auwera B, Braun J, Siegmund T, Herwig J. HLA-DRB1*04 and susceptibility to type 1 diabetes mellitus in a German/Belgian family and German case-control study. The Belgian Diabetes Registry. Tissue Antigens 2000; 55: 271–4
   PubMedGoogle Scholar
• Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Hajeer AH, Branas F, Dababneh A, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 2000; 79: 283–92
   PubMed Web of Science ®Google Scholar
• Mu H, Chen JJ, Jiang Y, King M-C, Thomson G, Criswell LA. Tumor necrosis factor a microsatellite polymorphism is associated with rheumatoid arthritis severity through an interaction with the HLA-DRB1 shared epitope. Arthritis Rheum 1999; 42: 438–42
   PubMed Web of Science ®Google Scholar
• Mattey DL, Hassell AB, Dawes PT, Ollier WER, Hajeer A. Interaction between tumor necrosis factor microsatellite polymorphisms and the HLA-DRB1 shared epitope in rheumatoid arthritis. Influence on disease outcome. Arthritis Rheum 1999; 42: 2698–704
   PubMed Web of Science ®Google Scholar